Intuitive Surgical reported $11.6B of revenue over the trailing twelve months, +20% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $11.6B (to Q3 2026). Net income: $2.96B, trailing twelve months to Q3 2026. Free cash flow: $3.60B, trailing twelve months to Q3 2026. Operating margin: 29%, trailing twelve months to Q3 2026.

ISRGIntuitive Surgical

Healthcare

$452.30+4.1% 1Y

$452.30

$332.4252 weeks$592.85

ISRG as reported

Intuitive Surgical reported $11.6B of revenue over the trailing twelve months, +20% on the year before. 10 reported series are charted on this page, each one as filed.

$11.6B

Revenue, trailing twelve months · to Q3 2026 · +20% against the twelve months before

Net income: $2.96B
Net income · +7.7% year on year · trailing twelve months to Q3 2026
Free cash flow: $3.60B
Free cash flow · +58% year on year · trailing twelve months to Q3 2026
Operating margin: 29%
Operating margin · trailing twelve months to Q3 2026

Details›

Every series Ryufin has for ISRG, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$11.6B	+20%	Q3 2026
Net income	$2.96B	+7.7%	Q3 2026
EPS	$8.26	+9.1%	Q3 2026
Gross margin	67%	n/a	Q3 2026
Operating margin	29%	n/a	Q3 2026
Net margin	26%	n/a	Q3 2026
ROE	17%	n/a	Q3 2026
ROA	15%	n/a	Q3 2026
Free cash flow	$3.60B	+58%	Q3 2026
P/E	54.8	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.